Patients who need cold-chain timing visibility will find the setup frustrating
1-8 Recent European Society of Cardiology guidelines for the management of cardiovascular disease (CVD) in patients with diabetes state that GLP-1 RAs (lixisenatide, liraglutide, semaglutide, exenatide extended release [ER], dulaglutide, efpeglenatide) should be considered for glucose-lowering treatment in patients with T2D at risk of or with heart failure (HF
Glutathione Glutathione blocks melanin by directly and indirectly stopping the enzyme tyrosinase, shifting away from producing dark eumelanin to making more of the lighter pheomelanin pigments
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
GLP-1 (glucagon-like peptide-1) receptor agonists form a class of medications that clinicians originally developed to help manage type 2 diabetes
Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin